ULURU Inc. announced that it has received $6 million in funding from Velocitas Partners, LLC

Altrazeal Life Sciences Inc., formerly ULURU Inc., is engaged in offering advanced topical solutions. The Company is a specialty medical technology company that is involved in developing and commercializing wound care and drug delivery systems based on its patented technologies. Its patented technology platforms include Altrazeal and OraDisc. Altrazeal is a new class of material designed to optimize the wound bed environment and accelerate healing. When applied to a moist wound, the powder interacts with the wound exudate and hydrates. OraDisc is a water-erodible pharmaceutical carrier device, the multi-layered device may be applied to mucosal surfaces, and adheres immediately, delivering actives to treat specific localized diseases/disorders. OraDisc technology can deliver drugs systemically across the mucosal surface or for the release of drugs into the oral cavity. The device causes minimum discomfort and provides erosion rates to deliver therapeutics over different time intervals.